CASP8 and urinary bladder cancer: As caspase-8, which is downstream in the death receptor pathway, is activated upon cisplatin treatment, it was, therefore, investigated whether factors involved in death receptor signaling were regulated in a different way in testicular and bladder cancer cell lines after cisplatin treatment.